33 results on '"Cher, Michael L."'
Search Results
2. Trials in the Key of G: Building Level 1 Evidence on the Real-world Effectiveness of Prostate Biomarkers
3. Practice-Level Variation in the Decision to Biopsy Prostate Imaging-Reporting and Data System 3 Lesions in Favorable-Risk Prostate Cancer Patients
4. Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer
5. Urologists’ Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients
6. Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance
7. Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic
8. Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium
9. Should all prostate needle biopsy Gleason score 4 + 4 = 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling
10. Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy
11. Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer
12. National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms
13. Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer
14. Establishment of a Web-based System for Collection of Patient-reported Outcomes After Radical Prostatectomy in a Statewide Quality Improvement Collaborative
15. PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate Cancer
16. Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells
17. C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis
18. Prostate Cancer Cell-Derived Urokinase-Type Plasminogen Activator Contributes to Intraosseous Tumor Growth and Bone Turnover
19. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis
20. Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase
21. Heterogeneous Activation of MMP-9 Due to Prostate Cancer-Bone Interaction
22. Cancer Interaction with the Bone Microenvironment
23. Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue
24. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy
25. Bone Microenvironment Modulates Expression and Activity of Cathepsin B in Prostate Cancer
26. Regulation of Gene Expression and Inhibition of Experimental Prostate Cancer Bone Metastasis by Dietary Genistein
27. Ten-Year Survival After Radical Prostatectomy: Specimen Gleason Score Is the Predictor in Organ-Confined Prostate Cancer
28. Presence of circulating prostate cancer cells in African American males adversely affects survival
29. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis
30. Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2
31. Stepwise Genetic Changes Associated with Progression of Nontumorigenic HPV-18 Immortalized Human Prostate Cancer-Derived Cell Line to a Malignant Phenotype
32. Predictors For Maximal Outcome in Patients Undergoing Salvage Surgery For Radio-Recurrent Prostate Cancer
33. Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.